These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 17722614

  • 1. [Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions].
    Mazo EB, Babanina GA.
    Urologiia; 2007; (3):15-9. PubMed ID: 17722614
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [High-dose trospium chloride in therapy of detrusor hyperreflexia].
    Madersbacher H, Stöhrer M, Richter R, Giannetti BM, Mürtz G.
    Urologe A; 1991 Jul; 30(4):260-3. PubMed ID: 1926674
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].
    Shvarts PG, Kadykov AS, Shvedkov VV, Timerbaeva SL, Polevaia EV, Mulach AN.
    Urologiia; 2009 Jul; (5):24-9. PubMed ID: 20213911
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.
    Fröhlich G, Bulitta M, Strösser W.
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):295-303. PubMed ID: 12139206
    [Abstract] [Full Text] [Related]

  • 10. [Solifenacin in the treatment of patients with hyperactive urinary bladder].
    Al-Shukri SKh, Kuz'min IV.
    Urologiia; 2007 Jul; (3):19-21. PubMed ID: 17722615
    [Abstract] [Full Text] [Related]

  • 11. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M, Madersbacher H, Palmtag H, Stöhrer M, Bödeker RH, P195 Study Group.
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [Abstract] [Full Text] [Related]

  • 12. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.
    Horstmann M, Schaefer T, Aguilar Y, Stenzl A, Sievert KD.
    Neurourol Urodyn; 2006 Nov; 25(5):441-5. PubMed ID: 16847942
    [Abstract] [Full Text] [Related]

  • 13. [Parasympathicolytic treatment of abnormal neurogenic bladder function: a urodynamic study (author's transl)].
    Wolters A, Sökeland J, Weil W, Kopf H.
    Dtsch Med Wochenschr; 1980 Sep 26; 105(39):1344-7. PubMed ID: 7460781
    [Abstract] [Full Text] [Related]

  • 14. [Combined treatment of voiding disorders in women with m-cholinolytic and alpha 1-adrenoblocker].
    Danilov VV, Vol'nykh IIu, Abdullaeva CK, Danilova TI.
    Urologiia; 2004 Sep 26; (3):49-52. PubMed ID: 15199816
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
    Staskin D, Sand P, Zinner N, Dmochowski R, Trospium Study Group.
    J Urol; 2007 Sep 26; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.